Publications by authors named "Clive Hawkins"

Claim this Profile
B
Brain reserve and physical disability in secondary progressive multiple sclerosis.
Nevin John, Yingtong Li, Floriana De Angelis, Jonathan Stutters, Ferran Prados Carrasco, Clive Hawkins

BMJ Neurol Open· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nicotinamide restricts neural precursor proliferation to enhance catecholaminergic neuronal subtype differentiation from mouse embryonic stem cells.
Síle M Griffin, Mark R Pickard, Clive P Hawkins, Adrian C Williams, Rosemary A Fricker

PLoS One· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial.
Jeremy Chataway, Floriana De Angelis, Peter Connick, Richard A Parker, Domenico Plantone, Clive Hawkins

Lancet Neurol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Th17 cells increase in RRMS as well as in SPMS, whereas various other phenotypes of Th17 increase in RRMS only.
S Kalra, C Lowndes, L Durant, R C Strange, A Al-Araji, Clive P Hawkins

Mult Scler J Exp Transl Clin· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation of tissue-type metabolic content in secondary progressive multiple sclerosis: a magnetic resonance spectroscopic imaging study.
Ian Marshall, Michael J Thrippleton, Mark E Bastin, Daisy Mollison, David A Dickie, Clive Hawkins

J Neurol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis.
Peter Connick, Floriana De Angelis, Richard A Parker, Domenico Plantone, Anisha Doshi, Clive Hawkins

BMJ Open· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary Excretion of Aluminium and Silicon in Secondary Progressive Multiple Sclerosis.
Krista Jones, Caroline Linhart, Clive Hawkins, Christopher Exley

EBioMedicine· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nicotinamide alone accelerates the conversion of mouse embryonic stem cells into mature neuronal populations.
Síle M Griffin, Mark R Pickard, Rowan P Orme, Clive P Hawkins, Adrian C Williams

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations between onset age and disability in multiple sclerosis patients studied using MSSS and a progression model.
Sudarshan Ramachandran, Richard C Strange, Peter W Jones, Seema Kalra, Devaki Nayak, Clive P Hawkins

Mult Scler Relat Disord· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nicotinamide promotes neuronal differentiation of mouse embryonic stem cells in vitro.
Síle M Griffin, Mark R Pickard, Rowan P Orme, Clive P Hawkins, Rosemary A Fricker

Neuroreport· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.

Nat Genet· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression of disability in multiple sclerosis: A study of factors influencing median time to reach an EDSS value.
Sudarshan Ramachandran, Richard C Strange, Seema Kalra, Devaki Nayak, Maurice P Zeegers, Clive P Hawkins

Mult Scler Relat Disord· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epileptic seizure abolition with aromatase inhibition.
Ka Wing Karen Chan, Seema Kalra, Robert Mark Kirby, Adrian Murray Brunt, Clive Paul Hawkins

J Neurol Neurosurg Psychiatry· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.

Nature· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Multiple Sclerosis Severity Score: associations with MC1R single nucleotide polymorphisms and host response to ultraviolet radiation.
Richard C Strange, Sudarshan Ramachandran, Maurice P Zeegers, Richard D Emes, Roby Abraham, Clive P Hawkins

Mult Scler· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor.
Maria Ban, An Goris, Aslaug R Lorentzen, Amie Baker, Tania Mihalova, Clive Hawkins

Eur J Hum Genet· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term combination of glatiramer acetate with i.v. steroid treatment preceding treatment with GA alone assessed by MRI-disease activity in patients with relapsing-remitting multiple sclerosis.
Nicola De Stefano, Massimo Filippi, Clive Hawkins,

J Neurol Sci· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A medical overview of encephalitis.
Mark J Stone, Clive P Hawkins

Neuropsychol Rehabil· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated urinary excretion of aluminium and iron in multiple sclerosis.
Christopher Exley, Godwin Mamutse, Olga Korchazhkina, Eleanor Pye, Stanislav Strekopytov, Clive Hawkins

Mult Scler· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene.
Anne Hinks, Anne Barton, Sally John, Ian Bruce, Clive Hawkins

Arthritis Rheum· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis